Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Mannkind Corp (MNKD)

Mannkind Corp (MNKD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Mannkind Corp 30930 RUSSELL RANCH ROAD SUITE 300 WESTLAKE VILLAGE CA 91362 USA

P: 818-661-5000

Description:

Mannkind Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for diseases such as diabetes, cancer, inflammatory and autoimmune diseases. The Company's lead product, the Technosphere Insulin System, consists of the Company's dry-powder Technosphere formulation of insulin and the Company's MedTone inhaler through which the powder is inhaled into the deep lung.

Key Statistics

Overview:

Market Capitalization, $K 206,681
Shares Outstanding, K 189,616
Annual Sales, $ 27,860 K
Annual Net Income, $ -86,980 K
Last Quarter Sales, $ 15,000 K
Last Quarter Net Income, $ -12,390 K
60-Month Beta 2.32
% of Insider Shareholders 1.02%
% of Institutional Shareholders 27.18%
Float, K 187,682
% Float 98.98%

Growth:

1-Year Return -3.54%
3-Year Return -77.76%
5-Year Return -96.94%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 81.56%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 08/07/19
Earnings Per Share ttm -0.37
EPS Growth vs. Prev Qtr 12.50%
EPS Growth vs. Prev Year 56.25%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00
Most Recent Split 1-5 on 03/03/17

MNKD Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -2.37
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) 0.00
Return-on-Assets (Before Tax) -72.88
Profit Margin % -312.20
Net Margin % N/A
Debt/Equity N/A
Price/Sales 7.08
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -1.03
Interest Coverage -8.19
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar